No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Taltz is a biologic drug used to treat moderate to severe plaque psoriasis in adults. It is a human interleukin-17A (IL-17A) inhibitor, which works by blocking the action of IL-17A, a protein that plays a role in the development of psoriasis. Taltz is administered as an injection under the skin, and is typically used in combination with other treatments such as topical medications and phototherapy.
Taltz is one of several biologic drugs used to treat psoriasis, and is one of the most widely prescribed biologics for the condition. It is generally well-tolerated, with the most common side effects being injection site reactions, upper respiratory tract infections, and headache.
The Taltz market is highly competitive, with several major pharmaceutical companies offering biologic drugs for the treatment of psoriasis. These include Eli Lilly, Novartis, AbbVie, Janssen, and Pfizer. Show Less Read more
